Grape powder attenuates the negative effects of GLP-1 receptor antagonism by exendin-3 (9-39) in a normoglycemic mouse model.

Prediabetes is a condition affecting 35% of US adults and about 50% of US adults age 65+. Foods rich in polyphenols, including flavanols and other flavonoids, have been studied for their putative beneficial effects on many different health conditions including type 2 diabetes mellitus and prediabetes. Studies have shown that some flavanols increase glucagon-like peptide 1 (GLP-1) secretion. GLP-1 is a feeding hormone that increases insulin secretion after carbohydrate consumption, and increased GLP-1 secretion may be responsible for some of the beneficial effects on glycemic control after flavanol consumption. The present study explored the effects of grape powder consumption on metrics of glycemic health in normoglycemic and prediabetic C57BL/6J mice; additionally, the mechanism of action of grape powder polyphenols was investigated. Grape powder significantly reduced (p < 0.01) blood glucose levels following oral glucose gavage after GLP-1 receptor antagonism by exendin-3 (9-39) compared to sugar-matched control, indicating that it was able to attenuate the hyperglycemic effects of GLP-1 receptor antagonism. Grape powder was employed in acute (1.6 g grape powder per kg bodyweight) and long-term high fat diet (grape powder incorporated into treatment diets at 5% w/w) feeding studies in normoglycemic and prediabetic (diet-induced obesity) mice; grape powder did not impove glycemic control in these studies versus sugar-matched control. The mechanisms by which grape powder ameliorates the deleterious effects of GLP-1 receptor antagonism warrant further study.

[1]  R. Hopkins,et al.  A polyphenol-rich fraction obtained from table grapes decreases adiposity, insulin resistance and markers of inflammation and impacts gut microbiota in high-fat-fed mice. , 2016, The Journal of nutritional biochemistry.

[2]  P. Richards,et al.  High fat diet impairs the function of glucagon-like peptide-1 producing L-cells , 2016, Peptides.

[3]  J. Serrano,et al.  Acutely administered grape-seed proanthocyanidin extract acts as a satiating agent. , 2016, Food & function.

[4]  P. Flatt,et al.  Differential molecular and cellular responses of GLP-1 secreting L-cells and pancreatic alpha cells to glucotoxicity and lipotoxicity. , 2015, Experimental cell research.

[5]  W. Hou,et al.  Anti-α-glucosidase and Anti-dipeptidyl Peptidase-IV Activities of Extracts and Purified Compounds from Vitis thunbergii var. taiwaniana. , 2015, Journal of agricultural and food chemistry.

[6]  K. Clément,et al.  Lipid-rich diet enhances L-cell density in obese subjects and in mice through improved L-cell differentiation , 2015, Journal of Nutritional Science.

[7]  M. Pinent,et al.  A grape seed extract increases active glucagon-like peptide-1 levels after an oral glucose load in rats. , 2014, Food & function.

[8]  M. Pinent,et al.  Grape-seed procyanidins modulate cellular membrane potential and nutrient-induced GLP-1 secretion in STC-1 cells. , 2014, American journal of physiology. Cell physiology.

[9]  M. Pinent,et al.  Grape-seed procyanidins prevent the cafeteria-diet-induced decrease of glucagon-like peptide-1 production. , 2014, Journal of agricultural and food chemistry.

[10]  Yujie Li,et al.  Grape seed proanthocyanidins ameliorate pancreatic beta-cell dysfunction and death in low-dose streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats partially by regulating endoplasmic reticulum stress , 2013, Nutrition & Metabolism.

[11]  M. Pinent,et al.  Grape seed procyanidins improve β-cell functionality under lipotoxic conditions due to their lipid-lowering effect. , 2013, The Journal of nutritional biochemistry.

[12]  H. Ashida,et al.  Cinnamtannin A2, a Tetrameric Procyanidin, Increases GLP-1 and Insulin Secretion in Mice , 2013, Bioscience, biotechnology, and biochemistry.

[13]  K. Khunti,et al.  Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis , 2013, Diabetologia.

[14]  Yujie Li,et al.  Grape seed proanthocyanidin extracts alleviate oxidative stress and ER stress in skeletal muscle of low-dose streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats. , 2013, Molecular nutrition & food research.

[15]  G. Xie,et al.  Differential effects of grape powder and its extract on glucose tolerance and chronic inflammation in high-fat-fed obese mice. , 2012, Journal of agricultural and food chemistry.

[16]  U. Boggi,et al.  A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets , 2012, Diabetologia.

[17]  S. Garcia-Vallvé,et al.  Grape seed-derived procyanidins decrease dipeptidyl-peptidase 4 activity and expression. , 2012, Journal of agricultural and food chemistry.

[18]  K. Watson,et al.  Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study , 2012, The Lancet.

[19]  A. Resende,et al.  Vitis vinifera L. grape skin extract activates the insulin‐signalling cascade and reduces hyperglycaemia in alloxan‐induced diabetic mice , 2012, The Journal of pharmacy and pharmacology.

[20]  L. Arola,et al.  Improvement of mitochondrial function in muscle of genetically obese rats after chronic supplementation with proanthocyanidins. , 2011, Journal of agricultural and food chemistry.

[21]  M. Blankenstein,et al.  Analysis of glucagon-like peptide 1; what to measure? , 2011, Clinica chimica acta; international journal of clinical chemistry.

[22]  R. Seeley,et al.  GLP-1 and energy balance: an integrated model of short-term and long-term control , 2011, Nature Reviews Endocrinology.

[23]  S. Adisakwattana,et al.  Grape seed extract supplementation prevents high-fructose diet-induced insulin resistance in rats by improving insulin and adiponectin signalling pathways , 2011, British Journal of Nutrition.

[24]  M. Mulero,et al.  Acute administration of grape seed proanthocyanidin extract modulates energetic metabolism in skeletal muscle and BAT mitochondria. , 2011, Journal of agricultural and food chemistry.

[25]  T. Slaga,et al.  Inhibition of Murine Skin Carcinogenesis by Freeze-Dried Grape Powder and Other Grape-Derived Major Antioxidants , 2010, Nutrition and cancer.

[26]  G. Pujadas,et al.  Effects of a grapeseed procyanidin extract (GSPE) on insulin resistance. , 2010, The Journal of nutritional biochemistry.

[27]  A. Scheen.  Dipeptidylpeptidase-4 Inhibitors (Gliptins) , 2010, Clinical pharmacokinetics.

[28]  R. Prior,et al.  Multi-laboratory validation of a standard method for quantifying proanthocyanidins in cranberry powders. , 2010, Journal of the science of food and agriculture.

[29]  G. Pujadas,et al.  Oligomers of grape-seed procyanidin extract activate the insulin receptor and key targets of the insulin signaling pathway differently from insulin. , 2010, The Journal of nutritional biochemistry.

[30]  F. Tabassam,et al.  Freeze-dried grape powder attenuates mitochondria- and oxidative stress-mediated apoptosis in liver cells. , 2009, Journal of agricultural and food chemistry.

[31]  D. Laight,et al.  Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[32]  Desmond E. Williams,et al.  Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006 , 2009, Diabetes Care.

[33]  Nihal Ahmad,et al.  Dose translation from animal to human studies revisited , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  J. Holst.  The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.

[35]  A. Vigé,et al.  C57BL/6J and A/J Mice Fed a High‐Fat Diet Delineate Components of Metabolic Syndrome , 2007, Obesity.

[36]  Tanja Y. Reuter.  Diet-induced models for obesity and type 2 diabetes , 2007 .

[37]  Jeppe Sturis,et al.  Small-molecule agonists for the glucagon-like peptide 1 receptor , 2007, Proceedings of the National Academy of Sciences.

[38]  Jungmin Lee,et al.  Determination of total monomeric anthocyanin pigment content of fruit juices, beverages, natural colorants, and wines by the pH differential method: collaborative study. , 2005, Journal of AOAC International.

[39]  R. Coleman,et al.  Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. , 2005, The Journal of nutrition.

[40]  B. Ahrén,et al.  The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. , 2004, Diabetes.

[41]  P. Flatt,et al.  Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin , 2003, Diabetologia.

[42]  A. Scalbert,et al.  Procyanidins are not bioavailable in rats fed a single meal containing a grapeseed extract or the procyanidin dimer B3 , 2002, British Journal of Nutrition.

[43]  J. Holst,et al.  Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. , 2001, The Journal of clinical endocrinology and metabolism.

[44]  D. Drucker,et al.  Exendin-(9-39) Is an Inverse Agonist of the Murine Glucagon-Like Peptide-1 Receptor: Implications for Basal Intracellular Cyclic Adenosine 3',5'-Monophosphate Levels and β-Cell Glucose Competence* *This work was supported by Grant 31-46958.96 from the Swiss National Science Foundation (to B.T.). , 1998, Endocrinology.

[45]  D. Drucker,et al.  Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling. , 1998, Diabetes.

[46]  B. Göke,et al.  Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans. , 1998, The Journal of clinical investigation.

[47]  A. Joyner,et al.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.

[48]  J. Rodin,et al.  Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. , 1995, Metabolism: clinical and experimental.

[49]  Shaoping Deng,et al.  Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor , 1993, Diabetes.

[50]  M. Feinglos,et al.  Diet-Induced Type II Diabetes in C57BL/6J Mice , 1988, Diabetes.

[51]  S. Salim,et al.  Grape powder prevents cognitive, behavioral, and biochemical impairments in a rat model of posttraumatic stress disorder. , 2015, Nutrition research.

[52]  R. Lamuela-Raventós,et al.  Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent , 1999 .

[53]  W. Dolci,et al.  Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence. , 1998, Endocrinology.